scispace - formally typeset
M

Miyuki Namatame

Researcher at Kitasato University

Publications -  28
Citations -  792

Miyuki Namatame is an academic researcher from Kitasato University. The author has contributed to research in topics: In vivo & Antiprotozoal. The author has an hindex of 17, co-authored 27 publications receiving 699 citations.

Papers
More filters
Journal ArticleDOI

Spoxazomicins A-C, novel antitrypanosomal alkaloids produced by an endophytic actinomycete, Streptosporangium oxazolinicum K07-0460(T).

TL;DR: Three novel antitrypanosomal alkaloids were isolated by silica gel column chromatography and HPLC from the culture broth of a new endophytic actinomycete species and shown to be new types of pyochelin family antibiotic.
Journal ArticleDOI

In vitro antimalarial activity of prenylated flavonoids from Erythrina fusca

TL;DR: Ethyl acetate extract from the stem bark of Erythrina fusca showed a antimalarial activity against the multi-drug-resistant strain (K1) of Plasmodium falciparum, and six flavonoids, lupinifolin, citflavanone, erythrisenegalone, lonchocarpol A, and 8-prenyldaidzein were isolated from the extract.
Journal ArticleDOI

Selective and Potent in Vitro Antitrypanosomal Activities of Ten Microbial Metabolites

TL;DR: This is the first report of antitrypanosomal activities of the 10 microbial metabolites listed above, and it is confirmed that these compounds are selective and potent against African trypanosomes.
Journal ArticleDOI

In vitro antitrypanosomal activity of plant terpenes against Trypanosoma brucei.

TL;DR: This finding represents the first report of promising trypanocidal activity of these terpenes and provides some valuable insight with regard to structure-activity relationships and the possible mode of action of the compounds.
Journal ArticleDOI

In vitro and in vivo antimalarial activity of puberulic acid and its new analogs, viticolins A–C, produced by Penicillium sp. FKI-4410

TL;DR: Puberulic acid demonstrated a therapeutic effect in vivo, which compared well against the currently used antimalarial drugs, and thus shows promise as a leading candidate for development into a new antimalaria compound.